Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development Study.
Empatica E4
bipolar disorder
deep learning
depression
digital biomarker
machine learning
major depressive disorder
mania
physiological data
wearable
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
04 05 2023
04 05 2023
Historique:
received:
29
12
2022
accepted:
07
03
2023
revised:
20
02
2023
medline:
8
5
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
epublish
Résumé
Depressive and manic episodes within bipolar disorder (BD) and major depressive disorder (MDD) involve altered mood, sleep, and activity, alongside physiological alterations wearables can capture. Firstly, we explored whether physiological wearable data could predict (aim 1) the severity of an acute affective episode at the intra-individual level and (aim 2) the polarity of an acute affective episode and euthymia among different individuals. Secondarily, we explored which physiological data were related to prior predictions, generalization across patients, and associations between affective symptoms and physiological data. We conducted a prospective exploratory observational study including patients with BD and MDD on acute affective episodes (manic, depressed, and mixed) whose physiological data were recorded using a research-grade wearable (Empatica E4) across 3 consecutive time points (acute, response, and remission of episode). Euthymic patients and healthy controls were recorded during a single session (approximately 48 h). Manic and depressive symptoms were assessed using standardized psychometric scales. Physiological wearable data included the following channels: acceleration (ACC), skin temperature, blood volume pulse, heart rate (HR), and electrodermal activity (EDA). Invalid physiological data were removed using a rule-based filter, and channels were time aligned at 1-second time units and segmented at window lengths of 32 seconds, as best-performing parameters. We developed deep learning predictive models, assessed the channels' individual contribution using permutation feature importance analysis, and computed physiological data to psychometric scales' items normalized mutual information (NMI). We present a novel, fully automated method for the preprocessing and analysis of physiological data from a research-grade wearable device, including a viable supervised learning pipeline for time-series analyses. Overall, 35 sessions (1512 hours) from 12 patients (manic, depressed, mixed, and euthymic) and 7 healthy controls (mean age 39.7, SD 12.6 years; 6/19, 32% female) were analyzed. The severity of mood episodes was predicted with moderate (62%-85%) accuracies (aim 1), and their polarity with moderate (70%) accuracy (aim 2). The most relevant features for the former tasks were ACC, EDA, and HR. There was a fair agreement in feature importance across classification tasks (Kendall W=0.383). Generalization of the former models on unseen patients was of overall low accuracy, except for the intra-individual models. ACC was associated with "increased motor activity" (NMI>0.55), "insomnia" (NMI=0.6), and "motor inhibition" (NMI=0.75). EDA was associated with "aggressive behavior" (NMI=1.0) and "psychic anxiety" (NMI=0.52). Physiological data from wearables show potential to identify mood episodes and specific symptoms of mania and depression quantitatively, both in BD and MDD. Motor activity and stress-related physiological data (EDA and HR) stand out as potential digital biomarkers for predicting mania and depression, respectively. These findings represent a promising pathway toward personalized psychiatry, in which physiological wearable data could allow the early identification and intervention of mood episodes.
Sections du résumé
BACKGROUND
Depressive and manic episodes within bipolar disorder (BD) and major depressive disorder (MDD) involve altered mood, sleep, and activity, alongside physiological alterations wearables can capture.
OBJECTIVE
Firstly, we explored whether physiological wearable data could predict (aim 1) the severity of an acute affective episode at the intra-individual level and (aim 2) the polarity of an acute affective episode and euthymia among different individuals. Secondarily, we explored which physiological data were related to prior predictions, generalization across patients, and associations between affective symptoms and physiological data.
METHODS
We conducted a prospective exploratory observational study including patients with BD and MDD on acute affective episodes (manic, depressed, and mixed) whose physiological data were recorded using a research-grade wearable (Empatica E4) across 3 consecutive time points (acute, response, and remission of episode). Euthymic patients and healthy controls were recorded during a single session (approximately 48 h). Manic and depressive symptoms were assessed using standardized psychometric scales. Physiological wearable data included the following channels: acceleration (ACC), skin temperature, blood volume pulse, heart rate (HR), and electrodermal activity (EDA). Invalid physiological data were removed using a rule-based filter, and channels were time aligned at 1-second time units and segmented at window lengths of 32 seconds, as best-performing parameters. We developed deep learning predictive models, assessed the channels' individual contribution using permutation feature importance analysis, and computed physiological data to psychometric scales' items normalized mutual information (NMI). We present a novel, fully automated method for the preprocessing and analysis of physiological data from a research-grade wearable device, including a viable supervised learning pipeline for time-series analyses.
RESULTS
Overall, 35 sessions (1512 hours) from 12 patients (manic, depressed, mixed, and euthymic) and 7 healthy controls (mean age 39.7, SD 12.6 years; 6/19, 32% female) were analyzed. The severity of mood episodes was predicted with moderate (62%-85%) accuracies (aim 1), and their polarity with moderate (70%) accuracy (aim 2). The most relevant features for the former tasks were ACC, EDA, and HR. There was a fair agreement in feature importance across classification tasks (Kendall W=0.383). Generalization of the former models on unseen patients was of overall low accuracy, except for the intra-individual models. ACC was associated with "increased motor activity" (NMI>0.55), "insomnia" (NMI=0.6), and "motor inhibition" (NMI=0.75). EDA was associated with "aggressive behavior" (NMI=1.0) and "psychic anxiety" (NMI=0.52).
CONCLUSIONS
Physiological data from wearables show potential to identify mood episodes and specific symptoms of mania and depression quantitatively, both in BD and MDD. Motor activity and stress-related physiological data (EDA and HR) stand out as potential digital biomarkers for predicting mania and depression, respectively. These findings represent a promising pathway toward personalized psychiatry, in which physiological wearable data could allow the early identification and intervention of mood episodes.
Identifiants
pubmed: 36939345
pii: v11i1e45405
doi: 10.2196/45405
pmc: PMC10196899
doi:
Substances chimiques
Biomarkers
0
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e45405Informations de copyright
©Gerard Anmella, Filippo Corponi, Bryan M Li, Ariadna Mas, Miriam Sanabra, Isabella Pacchiarotti, Marc Valentí, Iria Grande, Antoni Benabarre, Anna Giménez-Palomo, Marina Garriga, Isabel Agasi, Anna Bastidas, Myriam Cavero, Tabatha Fernández-Plaza, Néstor Arbelo, Miquel Bioque, Clemente García-Rizo, Norma Verdolini, Santiago Madero, Andrea Murru, Silvia Amoretti, Anabel Martínez-Aran, Victoria Ruiz, Giovanna Fico, Michele De Prisco, Vincenzo Oliva, Aleix Solanes, Joaquim Radua, Ludovic Samalin, Allan H Young, Eduard Vieta, Antonio Vergari, Diego Hidalgo-Mazzei. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 04.05.2023.
Références
PLoS One. 2020 Aug 24;15(8):e0231995
pubmed: 32833958
Eur Neuropsychopharmacol. 2022 Sep;62:36-45
pubmed: 35896055
IEEE J Biomed Health Inform. 2018 Sep;22(5):1385-1394
pubmed: 29990244
BMC Psychiatry. 2009 Jun 01;9:31
pubmed: 19486530
JAMA Psychiatry. 2019 Feb 1;76(2):190-198
pubmed: 30540352
Biol Res Nurs. 2016 Mar;18(2):213-20
pubmed: 26183182
J Neural Eng. 2019 Aug 14;16(5):051001
pubmed: 31151119
Psychol Med. 2022 Jun 14;:1-11
pubmed: 35699120
Physiol Meas. 2021 May 13;42(4):
pubmed: 33761477
Bipolar Disord. 2009 Aug;11(5):453-73
pubmed: 19624385
JMIR Form Res. 2021 Jul 21;5(7):e27891
pubmed: 34287205
JMIR Mhealth Uhealth. 2021 Mar 8;9(3):e24365
pubmed: 33683207
J Med Internet Res. 2022 Dec 21;24(12):e41042
pubmed: 36542427
JMIR Mhealth Uhealth. 2022 Oct 24;10(10):e35722
pubmed: 36279171
Int J Med Inform. 2023 May;173:105026
pubmed: 36893657
Eur Psychiatry. 2020 Feb 10;63(1):e10
pubmed: 32093802
Heliyon. 2020 Feb 04;6(2):e03274
pubmed: 32055728
Int J Bipolar Disord. 2018 May 6;6(1):9
pubmed: 29730832
Sci Data. 2018 Oct 16;5:180211
pubmed: 30325349
Psychophysiology. 2020 Oct;57(10):e13636
pubmed: 33460174
JAMA Psychiatry. 2017 Feb 01;74(2):189-196
pubmed: 28002572
N Engl J Med. 2020 Jul 2;383(1):58-66
pubmed: 32609982
Med Clin (Barc). 2002 Sep 28;119(10):366-71
pubmed: 12372167
J Psychiatr Res. 1988;22(1):21-8
pubmed: 3397906
JMIR Mhealth Uhealth. 2020 Aug 5;8(8):e18370
pubmed: 32755887
IEEE Trans Biomed Eng. 2018 Jul;65(7):1460-1467
pubmed: 28976309
Nat Rev Dis Primers. 2016 Sep 15;2:16065
pubmed: 27629598
JMIR Mhealth Uhealth. 2019 Dec 5;7(12):e14473
pubmed: 31804187
J Clin Med. 2021 Sep 25;10(19):
pubmed: 34640406
Front Digit Health. 2021 Apr 07;3:662811
pubmed: 34713137
Comput Methods Programs Biomed. 2021 Nov;212:106461
pubmed: 34736174
JMIR Form Res. 2021 Oct 7;5(10):e32656
pubmed: 34617905
Physiol Behav. 2015 Dec 1;152(Pt A):225-30
pubmed: 26434785
Acta Psychiatr Scand. 2011 Dec;124(6):495-6
pubmed: 21838736
JMIR Mhealth Uhealth. 2021 Jun 1;9(6):e26462
pubmed: 34061038
J Med Syst. 2020 Sep 23;44(11):190
pubmed: 32965570
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
J Affect Disord. 2016 Aug;200:58-66
pubmed: 27128358
Sensors (Basel). 2022 May 31;22(11):
pubmed: 35684797
Front Comput Neurosci. 2020 Jan 21;13:87
pubmed: 32038208
Eur Neuropsychopharmacol. 2019 Apr;29(4):471-481
pubmed: 30846287
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2600-2606
pubmed: 29531091
Eur Psychiatry. 2020 Feb 12;63(1):e12
pubmed: 32093795
Br J Psychiatry. 2017 Sep;211(3):169-174
pubmed: 28684405
IEEE J Biomed Health Inform. 2014 Nov;18(6):1865-73
pubmed: 25375684
PLoS One. 2014 Feb 20;9(2):e89574
pubmed: 24586883
Science. 2022 Jun 3;376(6597):1070-1074
pubmed: 35653486
J Med Internet Res. 2022 Jan 21;24(1):e30791
pubmed: 35060915
Eur Neuropsychopharmacol. 2022 Jul;60:100-116
pubmed: 35671641
Arch Gen Psychiatry. 1983 May;40(5):557-65
pubmed: 6838333
Psychol Med. 2019 Jan;49(2):200-211
pubmed: 30134999
JMIR Mhealth Uhealth. 2022 Jan 25;10(1):e34384
pubmed: 35076409
Sci Rep. 2019 Oct 3;9(1):14282
pubmed: 31582814
Eur Neuropsychopharmacol. 2020 Jun;35:49-60
pubmed: 32409261
Nat Biotechnol. 2015 May;33(5):462-3
pubmed: 25965751
J Clin Med. 2014;3(3):959-71
pubmed: 25530872
Eur Neuropsychopharmacol. 2022 May;58:39-41
pubmed: 35219178
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Schizophr Bull. 2020 Mar 10;:
pubmed: 32154882
Digit Biomark. 2019 Aug 16;3(2):92-102
pubmed: 32095769
J Affect Disord. 2018 Apr 1;230:84-86
pubmed: 29407543
J Psychiatr Res. 2018 Mar;98:59-63
pubmed: 29291581
JMIR Mhealth Uhealth. 2022 Jun 9;10(6):e35053
pubmed: 35679107
Biosensors (Basel). 2022 Jun 17;12(6):
pubmed: 35735574
Stress. 2013 Sep;16(5):520-30
pubmed: 23790072
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Neuropsychopharmacology. 2021 Jan;46(1):197-208
pubmed: 32919408
JMIR Mhealth Uhealth. 2023 May 4;11:e45405
pubmed: 36939345
JAMA. 2017 Oct 3;318(13):1215-1216
pubmed: 28973224
J Psychiatr Res. 2017 Jan;84:169-173
pubmed: 27743529
J Med Internet Res. 2022 Feb 2;24(2):e31565
pubmed: 35107440
Nat Rev Dis Primers. 2018 Mar 08;4:18008
pubmed: 29516993
IEEE Access. 2020;8:27074-27085
pubmed: 33747669
Transl Psychiatry. 2020 Jul 19;10(1):241
pubmed: 32684621
JMIR Ment Health. 2023 Jan 24;10:e42866
pubmed: 36692937
Eur Neuropsychopharmacol. 2021 Nov;52:94-95
pubmed: 34325190
Eur Neuropsychopharmacol. 2022 Oct;63:71-72
pubmed: 36081269
Front Psychiatry. 2020 Dec 18;11:584711
pubmed: 33391050
Depress Anxiety. 2019 Jan;36(1):63-71
pubmed: 30311742
Sci Rep. 2018 Nov 19;8(1):17030
pubmed: 30451895
Acta Psychiatr Scand. 2015 Feb;131(2):89-99
pubmed: 25430914
PLoS One. 2022 Jan 21;17(1):e0262232
pubmed: 35061801
JMIR Mhealth Uhealth. 2020 Nov 9;8(11):e18907
pubmed: 33164904
Front Behav Neurosci. 2022 Jun 23;16:856544
pubmed: 35813597
Arch Gen Psychiatry. 2010 Apr;67(4):339-47
pubmed: 20368510
NPJ Digit Med. 2019 Feb 1;2:3
pubmed: 31304353
BMC Psychiatry. 2018 Jan 25;18(1):22
pubmed: 29370787
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:6106-9
pubmed: 26737685
JMIR Mhealth Uhealth. 2021 Oct 25;9(10):e24872
pubmed: 34694233
Behav Res Methods. 2021 Apr;53(2):518-535
pubmed: 32748241
Transl Psychiatry. 2017 Aug 22;7(8):e1211
pubmed: 28892068
Acta Psychiatr Scand. 2016 May;133(5):368-77
pubmed: 26590799
Neurosci Biobehav Rev. 2017 Feb;73:68-80
pubmed: 27986468
Sensors (Basel). 2022 Apr 26;22(9):
pubmed: 35591007
Sensors (Basel). 2022 Sep 28;22(19):
pubmed: 36236461
Psychophysiology. 2019 Nov;56(11):e13441
pubmed: 31332802
JMIR Mhealth Uhealth. 2021 Apr 12;9(4):e24604
pubmed: 33843591
J Med Internet Res. 2023 Jan 19;25:e42672
pubmed: 36656625